Stifel Financial
ANRO icon

Stifel Financial’s Alto Neuroscience ANRO Stock Holding History

Stifel Financial’s Portfolio ANRO Stock Details ANRO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$2.26M Sell
85,480
-855
-1% -$19.8K ﹤0.01% 1985
2026
Q1 		$1.94M Sell
86,335
-829
-1% -$15.4K ﹤0.01% 1985
2025
Q4 		$1.55M Sell
87,164
-34,836
-29% -$439K ﹤0.01% 2122
2025
Q3 		$490K Sell
122,000
-4,853
-4% -$16.1K ﹤0.01% 2827
2025
Q2 		$279K Sell
126,853
-3,288
-3% -$7.82K ﹤0.01% 3090
2025
Q1 		$281K Buy
130,141
+1,441
+1% +$5.16K ﹤0.01% 3006
2024
Q4 		$544K Buy
+128,700
New +$803K ﹤0.01% 2618

Other funds holding ANRO

AWG
Alpha Wave Global New York $6.24B AUM 59.73% 1-Year Est. Return
CC
Commodore Capital New York $1.68B AUM 375.52% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
PA
Perceptive Advisors New York $6.66B AUM 360.84% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $71.3B AUM 56.8% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
SSC
Spruce Street Capital New York $510M AUM
VC
Vivo Capital Palo Alto, California $1.1B AUM 799.93% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return
AC
Armistice Capital New York $8.17B AUM 68.82% 1-Year Est. Return

Stifel Financial's ANRO Position: Q2 2026 in Review

Stifel Financial reduced its Alto Neuroscience (ANRO) stake by 0.99% in Q2 2026, selling an estimated $19.8K and leaving 85,480 shares worth $2.26M. The position accounts for ﹤0.01% of the portfolio, ranked #1985.

Stifel Financial first reported a position in ANRO in Q4 2024 and has held it in 7 quarters since. 114 funds tracked by Wall St. Rank hold ANRO as of Q2 2026.

  • Stifel Financial held 85,480 shares of Alto Neuroscience worth $2.26M as of Q2 2026.
  • Stifel Financial sold 855 Alto Neuroscience shares in Q2 2026, an estimated $19.8K.
  • Alto Neuroscience made up ﹤0.01% of Stifel Financial's portfolio in Q2 2026, its #1985 holding.
  • Stifel Financial first reported a position in Alto Neuroscience in Q4 2024 and has held it in 7 quarters since.
  • 114 funds tracked by Wall St. Rank held Alto Neuroscience as of Q2 2026.

Based on Stifel Financial's 13F filing for Q2 2026, filed 12 Aug 2026.